Cancer Genomics for Oncologists: Cancer Risk and Management of BRCA1 and BRCA2 Carriers

被引：0
|
作者：
Angela George
机构：
[1] Royal Marsden NHS Foundation Trust,Gynae Oncology Unit and Cancer Genetics Unit, The Institute of Cancer Research
[2] The Institute of Cancer Research,undefined
[3] Royal Marsden NHS Foundation Trust,undefined
来源：
Current Genetic Medicine Reports | 2019年 / 7卷
关键词：
Cancer predisposition genes; BRCA; Homologous recombination deficiency; Risk-reducing; High-risk screening; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：116 / 123
页数：7
相关论文
共 50 条
  • [41] Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
    Phillips, Kelly-Anne
    Milne, Roger L.
    Rookus, Matti A.
    Daly, Mary B.
    Antoniou, Antonis C.
    Peock, Susan
    Frost, Debra
    Easton, Douglas F.
    Ellis, Steve
    Friedlander, Michael L.
    Buys, Saundra S.
    Andrieu, Nadine
    Nogues, Catherine
    Stoppa-Lyonnet, Dominique
    Bonadona, Valerie
    Pujol, Pascal
    McLachlan, Sue Anne
    John, Esther M.
    Hooning, Maartje J.
    Seynaeve, Caroline
    Tollenaar, Rob A. E. M.
    Goldgar, David E.
    Terry, Mary Beth
    Caldes, Trinidad
    Weideman, Prue C.
    Andrulis, Irene L.
    Singer, Christian F.
    Birch, Kate
    Simard, Jacques
    Southey, Melissa C.
    Olsson, Hakan L.
    Jakubowska, Anna
    Olah, Edith
    Gerdes, Anne-Marie
    Foretova, Lenka
    Hopper, John L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3091 - 3099
  • [42] Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Mitchell, G
    Antoniou, AC
    Warren, R
    Peock, S
    Brown, J
    Davies, R
    Mattison, J
    Cook, M
    Warsi, I
    Evans, DG
    Eccles, D
    Douglas, F
    Paterson, J
    Hodgson, S
    Izatt, L
    Cole, T
    Burgess, L
    Eeles, R
    Easton, DF
    CANCER RESEARCH, 2006, 66 (03) : 1866 - 1872
  • [43] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Milne, Roger L.
    Osorio, Ana
    Ramon y Cajal, Teresa
    Baiget, Montserrat
    Lasa, Adriana
    Diaz-Rubio, Eduardo
    de la Hoya, Miguel
    Caldes, Trinidad
    Teule, Alex
    Lazaro, Conxi
    Blanco, Ignacio
    Balmana, Judith
    Sanchez-Olle, Gessami
    Vega, Ana
    Blanco, Ana
    Chirivella, Isabel
    Esteban Cardenosa, Eva
    Duran, Mercedes
    Velasco, Eladio
    Martinez de Duenas, Eduardo
    Tejada, Maria-Isabel
    Miramar, Maria-Dolores
    Calvo, Maria-Teresa
    Guillen-Ponce, Carmen
    Salazar, Raquel
    San Roman, Carlos
    Urioste, Miguel
    Benitez, Javier
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 221 - 232
  • [44] Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Kotsopoulos, J
    Lubinski, J
    Lynch, HT
    Neuhausen, SL
    Ghadirian, P
    Isaacs, C
    Weber, B
    Kim-Sing, C
    Foulkes, WD
    Gershoni-Baruch, R
    Ainsworth, P
    Friedman, E
    Daly, M
    Garber, JE
    Karlan, B
    Olopade, OI
    Tung, N
    Saal, HM
    Eisen, A
    Osborne, M
    Olsson, H
    Gilchrist, D
    Sun, P
    Narod, SA
    CANCER CAUSES & CONTROL, 2005, 16 (06) : 667 - 674
  • [45] Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers
    Antoniou, Antonis C.
    Shenton, Andrew
    Maher, Eamonn R.
    Watson, Emma
    Woodward, Emma
    Lalloo, Fiona
    Easton, Douglas F.
    Evans, D. Gareth
    BREAST CANCER RESEARCH, 2006, 8 (06)
  • [46] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Roger L. Milne
    Ana Osorio
    Teresa Ramón y Cajal
    Montserrat Baiget
    Adriana Lasa
    Eduardo Diaz-Rubio
    Miguel de la Hoya
    Trinidad Caldés
    Alex Teulé
    Conxi Lázaro
    Ignacio Blanco
    Judith Balmaña
    Gessamí Sánchez-Ollé
    Ana Vega
    Ana Blanco
    Isabel Chirivella
    Eva Esteban Cardeñosa
    Mercedes Durán
    Eladio Velasco
    Eduardo Martínez de Dueñas
    María-Isabel Tejada
    María-Dolores Miramar
    María-Teresa Calvo
    Carmen Guillén-Ponce
    Raquel Salazar
    Carlos San Román
    Miguel Urioste
    Javier Benítez
    Breast Cancer Research and Treatment, 2010, 119 : 221 - 232
  • [47] Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations
    Roukos, Dimitrios H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (15): : 1555 - 1556
  • [48] The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
    Iqbal, J.
    Ragone, A.
    Lubinski, J.
    Lynch, H. T.
    Moller, P.
    Ghadirian, P.
    Foulkes, W. D.
    Armel, S.
    Eisen, A.
    Neuhausen, S. L.
    Senter, L.
    Singer, C. F.
    Ainsworth, P.
    Kim-Sing, C.
    Tung, N.
    Friedman, E.
    Llacuachaqui, M.
    Ping, S.
    Narod, S. A.
    BRITISH JOURNAL OF CANCER, 2012, 107 (12) : 2005 - 2009
  • [49] Cancer risks among BRCA1 and BRCA2 mutation carriers
    E Levy-Lahad
    E Friedman
    British Journal of Cancer, 2007, 96 : 11 - 15
  • [50] Breast cancer survival in carriers of BRCA1 and BRCA2 mutations
    Rennert, G.
    Bisland, S.
    Bar Joseph, N.
    Zhang, S.
    Rennert, H. S.
    Barnett-Griness, O.
    Narod, S. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345